RxDoctor Payments DataLook up a doctor →

TAKHZYRO: payments to doctors

Payments that named TAKHZYRO as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$2.6M
Providers
4,223
Transactions
21,149
Average per transaction
$124

The per-transaction average — $124 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,223 providers the average total is $622, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Takeda Pharmaceuticals U.S.A., Inc.$2,102,00180.0%
Shire North American Group Inc$525,63220.0%
← All drugs & devices